Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals

Xinyu Tian1,2,3, Bo Huang1,2,3, Xiao-Peng Zhang4

  • 1National Laboratory of Solid State Microstructures, Nanjing University, Nanjing 210093, China.

Insights

This study models tumor suppression networks, revealing how oncogenic signals, p53 activation, and apoptosis pathways interact to control cell fate. It highlights the balance between pro-survival and pro-apoptotic signals in preventing cancer.

Area of Science:

  • Systems Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Tumor-suppressive mechanisms prevent uncontrolled cell growth.
  • The orchestration of these mechanisms remains poorly understood.
  • Key pathways involved in tumor repression are known but their dynamic interactions are elusive.

Purpose of the Study:

  • To build and analyze a dynamic network model of tumor suppression.
  • To elucidate the interplay between cell proliferation, p53 activation, and apoptosis.
  • To investigate how oncogenic and mitogenic signals influence cell fate decisions.

Main Methods:

  • Development of a three-module tumor-suppressive network model.
  • Numerical simulations of network dynamics under various stimuli (serum, E1A).
  • Analysis of kinetic properties like ultrasensitivity and bistability of p53.

Main Results:

  • Oncogenic signaling induces ARF, promoting p53 activation and inhibiting proliferation.
  • Mitogenic signaling activates E2F and Akt; p53/E2F1 induce apoptosis, while Akt/p21 repress it.
  • Cell fate (proliferation, arrest, apoptosis) depends on competing signals and p53 kinetics; E1A sensitizes cells to apoptosis.

Conclusions:

  • The study elucidates the roles of tumor suppressors and prosurvival factors in a dynamic context.
  • Network analysis reveals how competing signals dictate cell fate.
  • Provides a quantitative framework for exploring tumor suppression and potential therapeutic targets.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K